Webinar 2: What is the Role of the Newborn Screening Program Moving Forward with Tiered Testing
The purpose of this webinar was to explore the role of the newborn screening program to provide tiered testing, as more disorders are added to the Recommended Uniform Screening Panel (RUSP). Speakers examined the future application and feasibility of tiered testing for newborn screening disorders and the potential consequences. This is the second webinar in the four part series regarding conversations around tiered screening.
Sue Berry, MD, Professor and Director, University of Minnesota
J. Austin Hamm, MD, FACMG, Medical Director of Pediatric Genetics, East Tennessee Children’s Hospital
Joseph Orsini, PhD, Director of Operations for the New York State Newborn Screening Program, and the Director of the Lysosomal Storage Disorder Testing Laboratory
Kostas Petritis, PhD, Laboratory Chief, Biochemical Mass Spectrometry Laboratory, Newborn Screening and Molecular Biology Branch, Centers for Disease Control and Prevention
Miriam Schachter, PhD, Research Scientist, Newborn Screening Laboratory, New Jersey Department of Health
Link to archived webinar: http://www.aphl.org/612-20
APHL is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program, Florida and CPH recertification. P.A.C.E® is accepted by all licensure states except Florida. This webinar will provide 1.0 contact hour for participants who successfully complete the live or archived webinar. The deadline to receive P.A.C.E for the archived webinar is August 28, 2021.
This resource is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant # U22MC24078. This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the US Government.